The benchmark indices recorded losses of around two-tenths of a percent on May 15 following a couple of days of gains. Market breadth favoured the bears, with 1,914 shares declining against 1,016 advancing shares on the NSE. The market needs to deliver a sustainable close above the previous day's high for the upward journey. Below are some short-term trading ideas to consider:

Rajesh Palviya, Senior Vice President Research (Head of Research) at Axis Securities

AGI Infra | CMP: Rs 419.15

AGI Infra is in a strong uptrend across all time frames, as it continues to form higher tops and higher bottoms, indicating strength. On the weekly chart, the stock is trading within an “upward-sloping channel,” which reconfirms the bullish trend. On both the daily and weekly charts, the Bollinger Band buy signal indicates increased momentum.

Rising volumes over the past three months indicate increased participation in every rally. The stock is sustaining above its 20-, 50-, 100-, and 200-day simple moving averages (SMAs). These averages are also inching higher along with the price rise, which reconfirms bullish sentiment. The daily, weekly, and monthly Relative Strength Index (RSI) remains in favourable territory, indicating rising strength across all time frames.

Strategy: Buy

Target: Rs 440, Rs 465

Stop-Loss: Rs 394

Crompton Greaves Consumer Electricals | CMP: Rs 301.95

On the weekly chart, Crompton Greaves Consumer Electricals witnessed a breakout from a “double bottom” formation, confirming a short-term trend reversal. On both the daily and weekly charts, the stock is trending higher, forming a series of higher tops and higher bottoms, which indicates bullish sentiment. Rising volumes over the past three to four weeks signify increased participation at lower levels.

The stock is well placed above its 20-, 50-, 100-, and 200-day simple moving averages (SMAs). These averages are also inching higher along with the price rise, which reconfirms bullish sentiment. The daily, weekly, and monthly RSI remains in favourable territory, indicating rising strength across all time frames.

Strategy: Buy

Target: Rs 320, Rs 335

Stop-Loss: Rs 290

Zydus Lifesciences | CMP: Rs 1,011.7

On the daily and weekly timeframes, Zydus Lifesciences witnessed a short-term trend reversal around the Rs 960 level. On the daily chart, the stock also decisively surpassed the “multiple resistance” zone near Rs 960, accompanied by huge volumes, indicating a positive bias.

The daily and weekly Bollinger Band buy signals indicate increased momentum. The daily, weekly, and monthly RSI remains in favourable territory, indicating rising strength across all time frames. The stock is well placed above its 20-, 50-, 100-, and 200-day simple moving averages (SMAs). These averages are also inching higher along with the price rise, which reconfirms bullish sentiment.

Strategy: Buy

Target: Rs 1,060, Rs 1,120

Stop-Loss: Rs 990

Aditya Thukral, Founder & Analyst of AT Research & Risk Managers

Man Industries India | CMP: Rs 560.15

Man Industries has given a breakout from a small consolidation pattern with an expansion in volumes. This breakout has occurred after an extensive rally, signalling the continuation of a larger uptrend.

The stock has been in an uptrend, forming higher highs and higher lows while sustaining above all major EMAs, which are sloping upward. Previous resistance levels are now acting as supports, following the principle of polarity. The stock can be bought at current prices, with a stop-loss below Rs 530, as it has witnessed a breakout from a small consolidation range.

Strategy: Buy

Target: Rs 620

Stop-Loss: Rs 530

Krishna Institute of Medical Sciences | CMP: Rs 761.65

KIMS has been in an uptrend with the formation of higher highs and higher lows. The stock is consistently trading above all major EMAs, including the 20-day, 50-day, 100-day, and 200-day averages, all of which are sloping upward. The formation of a fresh higher high suggests the emergence of a new uptrend.

Additionally, the stock is sustaining above its previous resistance, which is now acting as support. The stock is currently undergoing a consolidation phase with declining volumes, a phenomenon often seen before a breakout in the direction of the prevailing trend, which in this case is upward.

The stock can be bought at current prices with a stop-loss below Rs 730, as the previous resistance levels have now turned into supports.

Strategy: Buy

Target: Rs 820

Stop-Loss: Rs 730

Anshul Jain, Head of Research at Lakshmishree Investments

Marksans Pharma | CMP: Rs 207.45

Marksans Pharma has confirmed a breakout from a 121-day double bottom formation on the daily charts, supported by a strong rise in volumes, indicating institutional participation and aggressive accumulation. The breakout reflects a decisive shift in sentiment, with the price structure transitioning from consolidation to expansion.

Follow-through momentum remains strong, and the setup suggests potential continuation toward the Rs 220–225 zone in the near term. Importantly, moving averages are positively aligned below the price, while momentum indicators continue to strengthen, creating a favourable backdrop for sustained upside. As long as the stock holds above the breakout zone, bulls are likely to remain in control and drive the next leg of the rally.

Strategy: Buy

Target: Rs 220, Rs 225

Stop-Loss: Rs 188

Rainbow Children's Medicare | CMP: Rs 1,336.2

Rainbow Children's Medicare has staged a strong recovery from the lower end of a 540-day rectangle formation, signalling renewed demand at critical support levels. The stock has now broken out of multiple inside-bar formations along with the swing high near Rs 1,315, indicating momentum expansion after prolonged consolidation.

The earlier sweep of the rectangle low helped flush out weak hands, adding strength to the current move. Rising moving averages are now acting as a dynamic support base, reinforcing the bullish structure. The immediate upside target is the next swing high near Rs 1,388, while a sustained move above that could open the path toward the rectangle top at Rs 1,641, which remains the larger bullish objective.

Strategy: Buy

Target: Rs 1,388, Rs 1,641

Stop-Loss: Rs 1,250

Nazara Technologies | CMP: Rs 300

Nazara Technologies has confirmed a breakout from a bullish 107-day double bottom formation, supported by an exceptional volume surge of more than 25 times the 50-day average, signalling broad-based participation and strong institutional interest. The breakout near Rs 294 marks a significant shift in momentum, with price action indicating a transition from accumulation to expansion.

The Rs 290–294 zone now becomes a crucial support and retest area. As long as the stock sustains above this band, the structure remains firmly bullish, and a rally toward the Rs 340 zone appears highly probable. Volume trends, positively aligned moving averages, and strengthening momentum indicators collectively suggest sustained upside potential in the near term.

Strategy: Buy

Target: Rs 340

Stop-Loss: Rs 275